SHSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/29/2026 15:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSHSE
Market Capitalization7,439.13 mln
Float215 mln
EPS
0.01
Overpriced
P / E
1,899
Bubble territory
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-1.91
Caution advised
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.43
Low leverage
Business Description
Founded in 2002 and based in Nanjing, China, Frontier Biotechnologies Inc. is a fully operational biopharmaceutical company that researches, produces, and sells medicines aimed at improving patient health. Its flagship product, Aikening, is an established treatment for HIV and AIDS, while its growing pipeline targets a range of serious conditions including kidney disease, high cholesterol, gout, bone loss, and liver disease. The company is also advancing treatments for pain affecting muscles, bones, and joints, reflecting its broad commitment to addressing unmet medical needs across multiple therapeutic areas.
